Storia della carriera di Magnus Ronn
Precedenti posizioni note di Magnus Ronn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | 01/01/2006 |
Roche Colorado Corp.
 Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Direttore Tecnico/Scientifico/R&S | - | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2011 | - |
Formazione di Magnus Ronn
| The University of Colorado | Undergraduate Degree |
| University of Uppsala | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Svezia | 2 |
Posizioni
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Roche Colorado Corp.
Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Health Technology |
- Borsa valori
- Insiders
- Magnus Ronn
- Esperienza
